| SIN_1003377 |
4 |
+
ATGAGGGAGCTTAGGCCACTGGTGCACTTGCTGTTGCCACTTTGTGTGCA
TTGGATTGCTGAAGAGATGACTGTTTCTGTGCTCGTTGATGTCACCACTA
ATGCTCTTTGTCCAGGCCACAAGACTTGTCCTCAAGCCATCTACATCAAT
GGCATCCAGCAAACTGTTGTTGGAATATTCAAGATGATAGTTCTTCCACT
CCTAGGTCAGCTGGCTGATGAGCATGGGCGTAAACCGTTGCTTCTTATCA
CTGTTTCCACAACTATTGTTCCTTTCACTTTACTTGCCATCAATCAATCA
AAAGCTTCTATATATGCTTACTATGTTCTCCGGACCATTTCTTATATCAT
AAGCCAGGGGAGCATTTTCTGCATTTCTGTTGCTTATGCTGCAGATGTTA
TTGATGACGACAAGAGGGCTGCTGCCTTTAGTTGGATCACAGGCCTGTTC
TCTGCATCACATGTCCTTGGAAACATCCTGGCACGTTTTCTTCCCGAAGA
TTACATATTTGCGGTGTCAATAGCTCTTTTGATCTTTGTTCCTATTTATA
TGTCGCTGTTTCTGACAGAAACAGTAAGACCAACTAGAAAGCCAGACCAG
CATATCCCTTGCTTAAACAAGGCATTTAAGATTGTTCAAGAACGATATTA
CTCAATGAAGCATGCTGCACATGTTGTTACCAGCAGCTCAACGCTTAAGC
GCATTTCTCTTGTTTCCTTCTTCTATGAATTGGGGATGTCTGGCATCAGC
AGTGTCTTATTGTACTATTTGAAGTCAGTTTTTGGTTTCAACAAAAATCA
ATTATCAGAAATCTTGATGATGGTTGGAGTCGGCTCAATTTTTTCTCAGA
TGCTGGTGCTTCCTCTACTCAACCCGTTGGTTGGAGAGAAACTGATTCTC
TGTGCAGGCTTGCTCGCATCAATAGCATATGGACTACTCTATGGCTTGGC
ATGGGCACCATGGGTACCGTATTTGAGTGCTTCTTTCGGAGTCATCTATA
TCCTTGTGAAACCTTCTACTTATGCTGTGATATCCAAGGCCTCAAACTCG
GCGGATCAGGGGAAAGCTCAAGGGTTTATCGCTGGCGTGCAATCCATTGC
AAGTCTGCTTTCGCCACTTGCAATGAGTCCACTTACGACATGGTTTCTAT
CCAGCAATGCTCCCTTCAACTGTAAGGGTTTCAGCATCATATTTGCATCC
ATAAGCATGGTGATTTCGTTGTGCTGTGCTTGGACGCTAAAGCTAGACGT
CCCGACCAACAAGAACGTGGAAGATACCAGGGAAGATATCGAAACACCAC
TTCTGTCGTAA
|
standard]
MRELRPLVHLLLPLCVHWIAEEMTVSVLVDVTTNALCPGHKTCPQAIYIN
GIQQTVVGIFKMIVLPLLGQLADEHGRKPLLLITVSTTIVPFTLLAINQS
KASIYAYYVLRTISYIISQGSIFCISVAYAADVIDDDKRAAAFSWITGLF
SASHVLGNILARFLPEDYIFAVSIALLIFVPIYMSLFLTETVRPTRKPDQ
HIPCLNKAFKIVQERYYSMKHAAHVVTSSSTLKRISLVSFFYELGMSGIS
SVLLYYLKSVFGFNKNQLSEILMMVGVGSIFSQMLVLPLLNPLVGEKLIL
CAGLLASIAYGLLYGLAWAPWVPYLSASFGVIYILVKPSTYAVISKASNS
ADQGKAQGFIAGVQSIASLLSPLAMSPLTTWFLSSNAPFNCKGFSIIFAS
ISMVISLCCAWTLKLDVPTNKNVEDTREDIETPLLS
|
IPR001958; Tetracycline resistance protein, TetA IPR011701; Major facilitator superfamily MFS-1 IPR020846; Major facilitator superfamily |
BIOINFORMATICS